Literature DB >> 14620978

An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery.

Robert Slappendel1, Ris Dirksen, Eric W G Weber, Dick B van der Schaaf.   

Abstract

In a previous prospective study, we confirmed that transfusion-related immunosuppression predisposes to postoperative infections, impairs the postoperative healing of wound and thereby prolongs hospitalization. This increases the well-known risks, such as transmission of infection or transfusion reactions, and has obliged us to revise our transfusion guidelines. We used a relational database containing information about 28,861 orthopedic surgery patients was used to determine when and how to improve these guidelines for transfusions. The survey showed the circumstances surrounding a high incidence of allogenic red cell infusions: failure to follow the guidelines, the preoperative use of nonselective NSAIDs, low preoperative Hb level, failure to retrieve blood, and high cut-off values for allogenic red cell transfusion. The first step was to determine the Hb level before giving red cell infusions and ensure compliance with predefined cut-off values. Subsequent measures included: use of COX 2-selective NSAIDs alone in the perioperative period; erythropoietin and iron therapy when the Hb level fell below 13 g/dL; use of cell salvage during and after surgery; administration of aprotinin to patients expected to have a high blood loss. The type of anesthesia had no blood-sparing effect. Although these steps can not be regarded as a new approach, we show that by following a strict rules with appropriate steps and in a concerted fashion, the use of allogenic red blood cells was reduced by 80%. Moreover, the amount of blood saved had other effects--e.g., the incidence of deep wound infections was reduced by 40%. The outcome is described in an algorithm summarizing the steps in a comprehensive perioperative diagram for giving blood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620978     DOI: 10.1080/00016470310017974

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  12 in total

1.  Autologous platelet gel in total knee arthroplasty: a prospective randomized study.

Authors:  Wieger G Horstmann; Robert Slappendel; Gijs G van Hellemondt; Ate W Wymenga; Nigel Jack; Peter A M Everts
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-07-18       Impact factor: 4.342

2.  Autologous blood transfusion following total knee arthroplasty: is it always necessary?

Authors:  N Tellisi; R Kakwani; N Hulse; G Abusitta; N Ashammakhi; K A H Wahab
Journal:  Int Orthop       Date:  2006-06-08       Impact factor: 3.075

Review 3.  Do autologous blood transfusion systems reduce allogeneic blood transfusion in total knee arthroplasty?

Authors:  Aditya Pawaskar; Abhijeet Ashok Salunke; Aashay Kekatpure; Yongsheng Chen; G I Nambi; Junhao Tan; Dhiraj Sonawane; Subodhkumar Pathak
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-16       Impact factor: 4.342

4.  Nonanemic patients do not benefit from autologous blood donation before total knee replacement.

Authors:  Stephen Kim; Eric Altneu; Jad Bou Monsef; Elizabeth A King; Thomas P Sculco; Friedrich Boettner
Journal:  HSS J       Date:  2011-06-14

5.  Nonanemic patients do not benefit from autologous blood donation before total hip replacement.

Authors:  Friedrich Boettner; Eric I Altneu; Brendan A Williams; Matthew Hepinstall; Thomas P Sculco
Journal:  HSS J       Date:  2009-12-05

6.  National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK.

Authors:  H Boralessa; D R Goldhill; K Tucker; A J Mortimer; J Grant-Casey
Journal:  Ann R Coll Surg Engl       Date:  2009-08-14       Impact factor: 1.891

7.  Testing the construct validity of hospital care quality indicators: a case study on hip replacement.

Authors:  Claudia Fischer; Hester F Lingsma; Helen A Anema; Job Kievit; Ewout W Steyerberg; Niek Klazinga
Journal:  BMC Health Serv Res       Date:  2016-10-05       Impact factor: 2.655

8.  Patient blood management in Europe.

Authors:  A Shander; H Van Aken; M J Colomina; H Gombotz; A Hofmann; R Krauspe; S Lasocki; T Richards; R Slappendel; D R Spahn
Journal:  Br J Anaesth       Date:  2012-05-24       Impact factor: 9.166

9.  Using theories of behaviour to understand transfusion prescribing in three clinical contexts in two countries: development work for an implementation trial.

Authors:  Jill J Francis; Alan Tinmouth; Simon J Stanworth; Jeremy M Grimshaw; Marie Johnston; Chris Hyde; Charlotte Stockton; Jamie C Brehaut; Dean Fergusson; Martin P Eccles
Journal:  Implement Sci       Date:  2009-10-24       Impact factor: 7.327

10.  Frequent use of blood-saving measures in elective orthopaedic surgery: a 2012 Dutch blood management survey.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Manon M Wentink; Cynthia So-Osman; Thea P M Vliet Vlieland; Ankie W M M Koopman-van Gemert; Rob G H H Nelissen; Leti Van Bodegom-Vos
Journal:  BMC Musculoskelet Disord       Date:  2013-08-05       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.